Clinical trials
Recruiting Phase 1/2 trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 9 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 7 |
| Bristol-Myers Squibb | 3 |
| University Hospital, Basel, Switzerland | 3 |
| Institute of Cancer Research, United Kingdom | 2 |
| University of Zurich | 2 |
| Debiopharm International SA | 1 |
| Eupraxia Pharmaceuticals Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Julien Bally | 1 |
| Kartos Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 4 |
| Esophageal Squamous Cell Carcinoma | 3 |
| Glioblastoma | 3 |
| Neoplasms | 3 |
| Carcinoma, Renal Cell | 2 |
| Colorectal Neoplasms | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Myelodysplastic Syndromes | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.